lean belly breakthrough reviews - Google News
Concert Pharma (CNCE) Announces FDA Lifts Clinical Hold on Clinical Trial with CTP-543 - StreetInsider.com
Concert Pharma (CNCE) Announces FDA Lifts Clinical Hold on Clinical Trial with CTP-543 StreetInsider.com In May 2017, the FDA informed the Company that a review of certain non-clinical toxicology studies was required before proceeding with dosing in the Phase 2a trial. Concert submitted the requested non-clinical study reports and in further discussions ... and more » |
No comments:
Post a Comment